XXXII Porto Cancer Meeting
April 22 @ 15:00 - April 24 @ 18:30

Bridging Research and Policy in Hereditary Cancer – a Joint Conference with the Horizon Europe Preventable project
It is our great pleasure to welcome you to the XXXII Edition of the Porto Cancer Meeting. This renowned international meeting has been organized since 1990 by the Institute of Molecular Pathology and Immunology of the University of Porto, well-known as Ipatimup.
The Porto Cancer Meeting is now a flagship meeting of the Institute for Research and Innovation in Health – i3S – the largest health research institute in Portugal. This scientific event will be part of the celebrations of the 10th Anniversary of i3S, highlighting a decade of scientific excellence, collaboration, and impact.
The XXXII Porto Cancer Meeting Theme in 2026
This Porto Cancer Meeting will be dedicated to heritable cancers, lying at the interface between basic research and real-world applications in the form of health policies.
To discuss challenges and opportunities, the XXXII Porto Cancer Meeting scientific program in 2026 will revolve around the genetics and biology of these cancers, their distinctive clinical pathways of care, social intricacies, and cost of healthcare for patients, hospitals and the society as a whole. This year, the Porto Cancer Meeting will embrace the final conference of the EU-funded project Preventable [www.preventable.eu], which has established pathways of care from several rare tumour risk syndromes, their respective costs and cost-effectiveness, as well as guidelines to improve communication between the various stakeholders moving around this ecosystem.
A special flavour brought in by the Preventable project is the presence of patients and families suffering from rare tumour risk syndromes, from many European countries, which have actively participated in the project, further extending the real impact of this event.
The meeting is expected to bring together patients, Healthcare Professionals, Scientists working in Basic and Clinical aspects of heritable cancers, Health Economics and Social Sciences, as well as Policy Officers and Health Managers from the European Health Management Association – EHMA, Decision-makers from Europe, and beyond. It will also mark the launch of the ‘Preventable Learning Hub’, a novel online resource of educational contents, designed specifically for at-risk individuals and their families, but also for healthcare providers and policymakers, integrating expert perspectives, real-life testimonies, visual infographics and guidelines, to promote knowledge, better decision-making, and evidence-based practices.
Register here.